ArticleCureus2025
Diagnostic and Invasive Colonoscopies Do Not Increase the Risk of Prosthetic Joint Infection After Reverse Shoulder Arthroplasty.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Reverse shoulder arthroplasty (RSA) is increasingly used to manage various degenerative and traumatic shoulder conditions. Prosthetic joint infection (PJI) remains a rare but serious complication, occurring in approximately 1-4% of cases. Given that colonoscopy can cause transient bacteremia - a potential risk factor for PJI - the current study aimed to determine whether undergoing diagnostic or invasive colonoscopy within one year after RSA is associated with an increased risk of PJI or all-cause revision surgery. Methods A retrospective cohort study was conducted using the PearlDiver All Payer Claims Database (MARINER). Patients who underwent RSA with at least three years of follow-up were identified and stratified into three groups: a control group (no colonoscopy), a diagnostic colonoscopy group, and an invasive colonoscopy group. The colonoscopy occurred within one year after undergoing the index procedure. Demographics, including age and sex, along with comorbidity data (using the Elixhauser Comorbidity Index), were collected. The primary outcomes assessed were the incidence of PJI and the rate of all-cause revision at 3 years postoperatively. Results A total of 1,244 patients in the diagnostic colonoscopy group, 2,973 in the invasive colonoscopy group, and 74,309 in the control group were identified. At three years postoperatively, the incidence of PJI was not significantly different between the diagnostic (3.94% vs. 3.29%, p = 0.20) or invasive (3.8% vs. 3.29%, p = 0.13) groups compared to controls. However, while the rate of all-cause revision in the diagnostic group (7.32% vs. 7.53%, p = 0.78) did not differ significantly from controls, the invasive colonoscopy group approached statistical significance (8.48% vs. 7.53%, p = 0.05) in univariate analysis and was statistically significant in multivariate analysis (OR = 1.63, p ≤ 0.01). Conclusion This study found that undergoing a diagnostic or invasive colonoscopy within one year after RSA does not increase the risk of PJI at three years postoperatively. However, patients who underwent invasive colonoscopy exhibited a higher rate of all-cause revision, which was statistically significant in multivariate analysis. These findings suggest that routine colonoscopy screening should not be deferred in RSA patients due to infection concerns, but the increased risk of revision following invasive colonoscopy highlights the need for further research to determine potential underlying factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.